The conference held last week in Bethesda, Md., looked at how the public was receiving information about their own genetics, as well as advances in the field via blogs and the mainstream media.
The National Functional Genomics Center will work with researchers from several institutions to find ovarian cancer markers.
The Nuffield Council is seeking comments on whether direct-to-consumer genetic tests need to be regulated.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.